Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Sell
6,727
-96
-1% -$11.2K 0.49% 34
2026
Q1
$824K Sell
6,823
-596
-8% -$68.8K 0.53% 31
2025
Q4
$781K Buy
7,419
+371
+5% +$34.8K 0.47% 37
2025
Q3
$592K Buy
7,048
+275
+4% +$22.6K 0.38% 42
2025
Q2
$536K Sell
6,773
-77
-1% -$6.12K 0.39% 44
2025
Q1
$615K Buy
6,850
+12
+0.2% +$1.12K 0.63% 33
2024
Q4
$680K Buy
6,838
+181
+3% +$18.7K 0.65% 27
2024
Q3
$756K Buy
6,657
+25
+0.4% +$2.97K 0.77% 24
2024
Q2
$821K Buy
6,632
+60
+0.9% +$7.73K 0.89% 21
2024
Q1
$861K Sell
6,572
-129
-2% -$15.9K 1.03% 20
2023
Q4
$731K Buy
+6,701
New +$696K 0.95% 21

Other funds holding MRK

OneFund LLC's MRK Position: Q2 2026 in Review

OneFund LLC reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $11.2K and leaving 6,727 shares worth $864K. The position accounts for 0.49% of the portfolio, ranked #34.

OneFund LLC first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • OneFund LLC held 6,727 shares of Merck worth $864K as of Q2 2026.
  • OneFund LLC sold 96 Merck shares in Q2 2026, an estimated $11.2K.
  • Merck made up 0.49% of OneFund LLC's portfolio in Q2 2026, its #34 holding.
  • OneFund LLC first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.